儿茶酚胺症的诊断与治疗  

Diagnosis and treatment of catecholamine syndrome

作　　者：段素静 张少玲[2] 

机构地区：[1]广东省珠海市拱北医院内科,519020 [2]中山大学第二附属医院

出　　处：《中国综合临床》2003年第11期990-991,共2页Clinical Medicine of China

摘　　要：目的探讨提高儿茶酚胺症的诊治水平的方法。方法回顾分析 1991～ 2 0 0 1年经手术和病理证实的儿茶酚胺症84例患者临床资料。结果 84例均经手术治疗 ,良性 76例 ,恶性 8例 ;肿瘤位于肾上腺 6 8例 ,异位嗜铬细胞瘤 8例 ,肾上腺髓质增生 8例。结论尿VMA检查是儿茶酚胺症定性诊断的主要依据 ,B超、CT、MRI检查为定位诊断的主要依据 ,13 1I MIBG检查同时为定性及定位的主要依据。根本治疗方法为手术切除 ,充分的术前准备 ,正确的围手术期处理 ,术后随访十分重要。Objective To evaluate the methods of raising the diagnosis and treatment level of catecholamine sydrome. Methods 84 cases of catecholamine syndrome, confirmed by surgery and pathology, were retrospectively analyzed. Results In 84 cases of catecholamine syndrome treated by surgery, 76 cases were benign and the other 8 cases were malignant. 68 cases were adrenal pheochromocytoma, 8 cases were extra-adrenal pheochromocytoma and 8 cases were adrenal medullary hyperplasia. Conclusion Urinary VMA provides the main evidence for the qualitative diagnosis of catecholamine sydrome and B-ultrasonography, CT and MRI provide the main evidences for the locative diagnosis,while 131 I-MIBG provide the main evidences for both the locative and qualitative diagnosis. Surgical resection is the basic means for curing catecholamine syndrome. Meticulous preoperative preparation, correct perioperatvie management and post-operative follow-up are of importance.

关 键 词：儿茶酚胺症 嗜铬细胞瘤 肾上腺髓质增生 诊断 治疗 

分 类 号：R54[医药卫生—心血管疾病]